Compare INNIO N.V. Ordinary Shares (INIO) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
INNIO N.V. Ordinary Shares vs Vaxcyte Inc. Common Stock — how do they compare? INNIO N.V. Ordinary Shares trades at $16 (market cap $13.73B), while Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B). The key difference: INNIO N.V. Ordinary Shares is the larger of the two by market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, INNIO N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold INNIO N.V. Ordinary Shares for 0 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| INIO | PCVX | |
|---|---|---|
Market Cap | $13.73B | $10.51B |
Volume | 5,012,195 | 2,644,694 |
Sector | Industrials | Health |
52-Week High | $41.13 | $73.82 |
52-Week Low | $16.50 | $40.32 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $15.39B | $9.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About INNIO N.V. Ordinary Shares
INNIO Group designs, manufactures, and services reciprocating gas engines for distributed power generation under its Jenbacher and Waukesha brands, serving applications from data centers to industrial and grid-stabilization uses.
Read more on INIO →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
